NovoCure Ltd — Director's Dealing 2019

Jan 14, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-01-10

Reporting Person: GROENHUYSEN WILHELMUS CM (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-10	Ordinary Shares	A	25	$27.20	Acquired	37149	Direct
2019-01-11	Ordinary Shares	M	30000	$3.44	Acquired	67149	Direct
2019-01-11	Ordinary Shares	S	30000	$42.35	Disposed	37149	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-11	Options to Buy Ordinary Shares	$3.44	M	30000	Disposed	2021-12-13	Ordinary Shares (30000)	Direct

Footnotes

F1: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2018 through December 31, 2018. This transaction is also exempt under Rule 16b-3(c).

F2: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on July 2, 2018.

F3: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen.

F4: Options exercised were fully vested as of the date hereof.